AAAAAA
Results:
1-17
|
Results: 17
Authors:
Alric, L
Duffaut, M
Selves, J
Sandre, K
Mularczyck, M
Izopet, J
Desmorat, H
Bureau, C
Chaouche, N
Dalbergue, B
Vinel, JP
Citation: L. Alric et al., Maintenance therapy with gradual reduction of the interferon dose over oneyear improves histological response in patients with chronic hepatitis C with biochemical response: results of a randomized trial, J HEPATOL, 35(2), 2001, pp. 272-278
Authors:
Bureau, C
Bernad, J
Chaouche, N
Orfila, C
Beraud, M
Gonindard, C
Alric, L
Vinel, JP
Pipy, B
Citation: C. Bureau et al., Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase, J BIOL CHEM, 276(25), 2001, pp. 23077-23083
Authors:
Peron, JM
Barange, K
Otal, P
Rousseau, H
Payen, JL
Pascal, JP
Joffre, F
Vinel, JP
Citation: Jm. Peron et al., Transjugular intrahepatic portosystemic shunts in the treatment of refractory ascites: Results in 48 consecutive patients, J VAS INT R, 11(9), 2000, pp. 1211-1216
Authors:
Alric, L
Orfila, C
Carrere, N
Beraud, M
Carrera, G
Lepert, JC
Duffaut, M
Pipy, B
Vinel, JP
Citation: L. Alric et al., Reactive oxygen intermediates and eicosanoid production by Kupffer cells and infiltrated macrophages in acute and chronic liver injury induced in rats by CCl4, INFLAMM RES, 49(12), 2000, pp. 700-707
Authors:
Vinel, JP
Citation: Jp. Vinel, Comments on case report: Hemorrhage from ruptured esophageal varices in acute alcoholic hepatitis in a patient with cirrhosis, GASTRO CL B, 24(1), 2000, pp. 107-108
Authors:
Escorsell, A
Del Arbol, LR
Planas, R
Albillos, A
Banares, R
Cales, P
Pateron, D
Bernard, B
Vinel, JP
Bosch, J
Citation: A. Escorsell et al., Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: The TEST study, HEPATOLOGY, 32(3), 2000, pp. 471-476
Authors:
Cales, P
Lacave, N
Silvain, C
Vinel, JP
Besseghir, K
Lebrec, D
Citation: P. Cales et al., Prospective study on the application of the Baveno II Consensus Conferencecriteria in patients with cirrhosis and gastrointestinal bleeding, J HEPATOL, 33(5), 2000, pp. 738-741
Authors:
Sandres, K
Dubois, M
Pasquier, C
Payen, JL
Alric, L
Duffaut, M
Vinel, JP
Pascal, JP
Puel, J
Izopet, J
Citation: K. Sandres et al., Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy, J VIROLOGY, 74(2), 2000, pp. 661-668
Authors:
Robson, KJH
Merryweather-Clark, AT
Pointon, JJ
Shearman, JD
Halsall, DJ
Kelly, A
Cox, TM
Rosenberg, WM
Howell, M
Eccles, D
Patch, C
Fowler, AV
Wallace, DF
Camaschella, C
Roetto, A
Zecchina, G
De Gobbi, M
Gasparini, P
Cadet, E
Vandwalle, JL
Capron, D
Rochette, J
Borot, N
Demangel, C
Dery, R
Vinel, JP
Pascal, JP
Coppin, H
Roth, MP
Citation: Kjh. Robson et al., Diagnosis and management of haemochromatosis since the discovery of the HFE gene: A European experience, BR J HAEM, 108(1), 2000, pp. 31-39
Authors:
Alric, L
Fort, M
Izopet, J
Vinel, JP
Bureau, C
Sandre, K
Charlet, JP
Beraud, M
Abbal, M
Duffaut, M
Citation: L. Alric et al., Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance, TISSUE ANTI, 56(2), 2000, pp. 154-158
Authors:
Otal, P
Rousseau, H
Vinel, JP
Ducoin, H
Hassissene, S
Joffre, F
Citation: P. Otal et al., High occlusion rate in experimental transjugular intrahepatic portosystemic shunt created with a Dacron-covered nitinol stent, J VAS INT R, 10(2), 1999, pp. 183-188
Treatment of refractory hydrothorax in cirrhosis with transjugular intrahepatic porto-systemic shunt
Authors:
Peron, JM
Dupuis, E
Alric, L
Ottal, P
Rousseau, H
Barange, K
Payen, JL
Pascal, JP
Vinel, JP
Citation: Jm. Peron et al., Treatment of refractory hydrothorax in cirrhosis with transjugular intrahepatic porto-systemic shunt, GASTRO CL B, 23(3), 1999, pp. 414-415
Authors:
Barange, K
Peron, JM
Imani, K
Otal, P
Payen, JL
Rousseau, H
Pascal, JP
Joffre, F
Vinel, JP
Citation: K. Barange et al., Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices, HEPATOLOGY, 30(5), 1999, pp. 1139-1143
Authors:
Alric, L
Izopet, J
Fort, M
Vinel, JP
Fontenelle, P
Orfila, C
Payen, JL
Sandres, K
Desmorat, H
Charlet, JP
Duffaut, M
Abbal, M
Citation: L. Alric et al., Study of the association between major histocompatibility complex class IIgenes and the response to interferon alpha in patients with chronic hepatitis C infection, HUMAN IMMUN, 60(6), 1999, pp. 516-523
Authors:
Alric, L
Fort, M
Izopet, J
Vinel, JP
Duffaut, M
Abbal, M
Citation: L. Alric et al., Association between genes of the major histocompatibility complex class IIand the outcome of hepatitis C virus infection, J INFEC DIS, 179(5), 1999, pp. 1309-1310
Authors:
Orfila, C
Lepert, JC
Alric, L
Carrera, G
Beraud, M
Vinel, JP
Pipy, B
Citation: C. Orfila et al., Expression of TNF-alpha and immunohistochemical distribution of hepatic macrophage surface markers in carbon tetrachloride-induced chronic liver injury in rats, HISTOCHEM J, 31(10), 1999, pp. 677-685
Evaluation of alpha-fetoprotein assay in ascitic fluid for the diagnosis of hepatocellular carcinoma
Authors:
Miedouge, M
Salama, G
Barange, K
Vincent, C
Vinel, JP
Serre, G
Citation: M. Miedouge et al., Evaluation of alpha-fetoprotein assay in ascitic fluid for the diagnosis of hepatocellular carcinoma, CLIN CHIM A, 280(1-2), 1999, pp. 161-171
Risultati:
1-17
|